대장암 환자에서 항암 화학요법 후 발생한 호중구 감소성 대장염 1예
Neutropenic Enterocolitis after Chemotherapy for Colon Cancer
천정우, 홍성우, 장여구, 이혜경, 이혁상,
소속 상세정보
천정우 ( Chun Jung-Woo )
인제대학교 의과대학 서울백병원 외과학교실
홍성우 ( Hong Seong-Woo )
인제대학교 의과대학 서울백병원 외과학교실
장여구 ( Chang Yeo-Goo )
인제대학교 의과대학 서울백병원 외과학교실
이혜경 ( Lee Hye-Kyung )
인제대학교 의과대학 서울백병원 병리학교실
이혁상 ( Lee Hyuck-Sang )
인제대학교 의과대학 서울백병원 외과학교실
KMID : 0356720060220010062
Abstract
Neutropenic enterocolitis is observed in approximately 10∼46% of patients with acute leukemia, as well as in patients with other diseases, like acquired immunodeficiency syndrom (AIDS), that lead to profound neutropenia. Patients who become neutropenic after combined chemotherapy are at special risk of developing neutropenic enterocolitis. With the recently increasing numbers of patients with solid tumors treated with high-dose chemotherapy, the frequency of this disease is expected to increase. However, this disease has been rarely reported in patients with colon cancer treated with leucovorin and 5-fluorouracil for adjuvant chemotherapy. We report a case of neutropenic enterocolitis after a treatment of 5-fluorouracil and leucovorin for sigmoid colon cancer. J Korean Soc Coloproctol 2006;22:62-65
키워드
호중구 감소성 대장염;대장암;항암화학요법
Neutropenic enterocolitis;Colon cancer;Chemotherapy
원문 및 링크아웃 정보
등재저널 정보